Dafna Capital Management LLC 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
Dafna Capital Management LLC disclosed 88 US equity positions worth $524.4m in its Q2 2026 13F filing. The largest position was RVMD at 20.1% of the reported book, followed by XBI and CMPS. Against the Q1 2026 filing, it opened 4 new positions, added to 12 and reduced 17 among the top 50 holdings.
What did Dafna Capital Management LLC own in Q2 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | RVMD REVOLUTION MEDICINES INC | Healthcare | 20.1% | $105.4m | 562,630 | -3% | reduced |
| 2 | XBI SPDR S&P BIOTECH ETF | 5.9% | $31.1m | 196,505 | -38% | reduced | |
| 3 | CMPS COMPASS PATHWAYS PLC | Healthcare | 5.4% | $28.5m | 2,011,952 | -17% | reduced |
| 4 | STXS STEREOTAXIS INC | 4.5% | $23.5m | 13,680,554 | 0% | held | |
| 5 | NKTR NEKTAR THERAPEUTICS | Healthcare | 4.2% | $22.2m | 318,380 | 93% | added |
| 6 | DNLI DENALI THERAPEUTICS INC | Healthcare | 3.6% | $19.0m | 739,014 | 132% | added |
| 7 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 3.5% | $18.5m | 497,240 | 4% | added |
| 8 | ATRC ATRICURE INC | Healthcare | 3.2% | $16.7m | 597,431 | 0% | held |
| 9 | XENE XENON PHARMACEUTICALS INC | Healthcare | 2.9% | $15.1m | 250,772 | 0% | held |
| 10 | CYTK CYTOKINETICS INC | Healthcare | 2.8% | $14.7m | 171,998 | -21% | reduced |
| 11 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 2.6% | $13.6m | 441,829 | -0% | held |
| 12 | ASND ASCENDIS PHARMA A/S | Healthcare | 2.5% | $12.9m | 48,469 | – | new |
| 13 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 1.9% | $9.7m | 57,769 | -18% | reduced |
| 14 | AXGN AXOGEN INC | Healthcare | 1.8% | $9.7m | 208,960 | -16% | reduced |
| 15 | PODD INSULET CORP | Healthcare | 1.8% | $9.4m | 61,870 | 469% | added |
| 16 | EWTX EDGEWISE THERAPEUTICS INC | Healthcare | 1.8% | $9.2m | 226,819 | 102% | added |
| 17 | BCAX BICARA THERAPEUTICS INC | Healthcare | 1.6% | $8.5m | 284,955 | -32% | reduced |
| 18 | IBB ISHARES NASDAQ BIOTECH INDX | 1.5% | $8.1m | 42,595 | -31% | reduced | |
| 19 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 1.4% | $7.3m | 335,255 | 54% | added |
| 20 | MPLT MAPLIGHT THERAPEUTICS INC | 1.2% | $6.1m | 171,006 | 0% | held | |
| 21 | LRMR LARIMAR THERAPEUTICS INC | Healthcare | 1.2% | $6.1m | 2,008,164 | -1% | reduced |
| 22 | IPSC CENTURY THERAPEUTICS INC | Healthcare | 1.1% | $5.9m | 2,400,458 | -1% | reduced |
| 23 | DXCM DEXCOM INC | Healthcare | 1.1% | $5.8m | 86,279 | 0% | held |
| 24 | IMVT IMMUNOVANT INC | Healthcare | 1.1% | $5.8m | 149,524 | -1% | reduced |
| 25 | INGN INOGEN INC | Healthcare | 1.0% | $5.5m | 845,179 | 0% | held |
| 26 | TNDM TANDEM DIABETES CARE INC | Healthcare | 1.0% | $5.4m | 355,208 | 0% | held |
| 27 | ALKS ALKERMES PLC | Healthcare | 1.0% | $5.3m | 101,266 | -27% | reduced |
| 28 | STOK STOKE THERAPEUTICS INC | Healthcare | 0.8% | $4.3m | 130,875 | 0% | held |
| 29 | ALLO ALLOGENE THERAPEUTICS INC | Healthcare | 0.8% | $4.2m | 2,000,000 | 46% | added |
| 30 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 0.8% | $4.0m | 400,248 | -7% | reduced |
| 31 | LKFT LAKEFRONT BIOTHERAPEUTICS NV | Healthcare | 0.7% | $3.9m | 130,175 | 0% | held |
| 32 | KIDS ORTHOPEDIATRICS CORP | Healthcare | 0.7% | $3.6m | 189,130 | 98% | added |
| 33 | HELP CYBIN INC | 0.6% | $3.4m | 514,061 | 3% | added | |
| 34 | RAPP RAPPORT THERAPEUTICS INC | 0.6% | $3.1m | 75,000 | 0% | held | |
| 35 | KYMR KYMERA THERAPEUTICS INC | Healthcare | 0.6% | $3.1m | 27,000 | – | new |
| 36 | PROQR THERAPEUTICS NV | 0.5% | $2.8m | 1,530,361 | -2% | reduced | |
| 37 | NGNE NEUROGENE INC | 0.5% | $2.8m | 89,032 | 57% | added | |
| 38 | ANL ADLAI NORTYE LTD | 0.5% | $2.8m | 239,553 | – | new | |
| 39 | PRCT PROCEPT BIOROBOTICS CORP | Healthcare | 0.5% | $2.7m | 120,000 | 0% | held |
| 40 | AQST AQUESTIVE THERAPEUTICS INC | 0.5% | $2.7m | 645,915 | 75% | added | |
| 41 | CLDX CELLDEX THERAPEUTICS INC | Healthcare | 0.5% | $2.5m | 68,518 | 0% | held |
| 42 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 0.5% | $2.5m | 46,500 | 0% | held |
| 43 | ALGN ALIGN TECHNOLOGY INC | Healthcare | 0.5% | $2.4m | 14,000 | -7% | reduced |
| 44 | VKTX VIKING THERAPEUTICS INC | Healthcare | 0.4% | $2.3m | 59,516 | 0% | held |
| 45 | NERVGEN PHARMA CORP | 0.4% | $2.2m | 1,050,000 | – | new | |
| 46 | BHVN BIOHAVEN LTD | Healthcare | 0.4% | $2.0m | 137,593 | -84% | reduced |
| 47 | MAZE MAZE THERAPEUTICS INC | Healthcare | 0.4% | $1.9m | 65,000 | 86% | added |
| 48 | ALEC ALECTOR INC | Healthcare | 0.3% | $1.8m | 908,351 | 0% | held |
| 49 | LXEO LEXEO THERAPEUTICS INC | Healthcare | 0.3% | $1.8m | 377,059 | 0% | held |
| 50 | PROF PROFOUND MEDICAL CORP | 0.3% | $1.7m | 260,360 | -1% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.